Delivery Order SPE2DB20D3304-SPE2DB25FW8H0
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,866.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, with an ultimate completion date of July 24, 2025, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. This award involved no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Multaq 400 mg tablets (60-count units) valued at $4,589.64. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,337.56. The order was competitively awarded without set-aside provisions and is scheduled for completion by July 25, 2025. Multaq is an antiarrhythmic medication used in the treatment of atrial fibrillation, reflecting the pharmaceutical distributor's role in supplying critical medications to federal...
- The Defense Logistics Agency awarded a $13,503.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Multaq 400 mg, a pharmaceutical product used in cardiac arrhythmia management. This firm fixed price contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-competitive delivery order executed under an existing contract vehicle. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $6,661.37 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This firm fixed price, competitively awarded contract—with no set-aside designation—was executed on July 22, 2025, with an ultimate completion date of July 23, 2025. The award reflects a rapid fulfillment timeline typical of delivery orders placed against existing contract vehicles. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $7K to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price contract with no set-aside designation was executed on July 28, 2025, with an ultimate completion date of July 29, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- This delivery order, awarded on July 21, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $7,781.08. The contract utilizes a firm fixed price structure and is non-competitive, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,170.01 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $4,632.34 delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is listed as Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Multaq 400 mg tablets in a quantity of 60 units, valued at $24,080.88 under a firm fixed-price contract. This is a non-set-aside award, meaning it was competitively procured and open to all qualified vendors. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...